AVICANNA INC (AVCN.CA) Fundamental Analysis & Valuation
TSX:AVCN • CA05368K1003
Current stock price
0.175 CAD
-0.01 (-2.78%)
Last:
This AVCN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AVCN.CA Profitability Analysis
1.1 Basic Checks
- In the past year AVCN has reported negative net income.
- In the past year AVCN has reported a negative cash flow from operations.
- AVCN had negative earnings in each of the past 5 years.
- In the past 5 years AVCN always reported negative operating cash flow.
1.2 Ratios
- AVCN has a Return On Assets of -8.87%. This is comparable to the rest of the industry: AVCN outperforms 51.52% of its industry peers.
- Looking at the Return On Equity, with a value of -60.37%, AVCN is doing worse than 60.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.87% | ||
| ROE | -60.37% | ||
| ROIC | N/A |
ROA(3y)-47.14%
ROA(5y)-65.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AVCN's Gross Margin of 51.95% is fine compared to the rest of the industry. AVCN outperforms 75.76% of its industry peers.
- AVCN's Gross Margin has improved in the last couple of years.
- AVCN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.95% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.65%
GM growth 5Y8.17%
2. AVCN.CA Health Analysis
2.1 Basic Checks
- AVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AVCN has been increased compared to 1 year ago.
- AVCN has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for AVCN has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -4.67, we must say that AVCN is in the distress zone and has some risk of bankruptcy.
- AVCN's Altman-Z score of -4.67 is on the low side compared to the rest of the industry. AVCN is outperformed by 75.76% of its industry peers.
- There is no outstanding debt for AVCN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.67 |
ROIC/WACCN/A
WACC8.5%
2.3 Liquidity
- AVCN has a Current Ratio of 0.90. This is a bad value and indicates that AVCN is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.90, AVCN is doing worse than 84.85% of the companies in the same industry.
- AVCN has a Quick Ratio of 0.90. This is a bad value and indicates that AVCN is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of AVCN (0.38) is worse than 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.38 |
3. AVCN.CA Growth Analysis
3.1 Past
- AVCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.08%, which is quite impressive.
- The Revenue has been growing slightly by 2.41% in the past year.
- Measured over the past years, AVCN shows a very strong growth in Revenue. The Revenue has been growing by 172.32% on average per year.
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.13%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y98.2%
Revenue growth 5Y172.32%
Sales Q2Q%1.96%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. AVCN.CA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AVCN. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. AVCN.CA Dividend Analysis
5.1 Amount
- AVCN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AVCN.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:AVCN (3/13/2026, 7:00:00 PM)
0.175
-0.01 (-2.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-14 2025-11-14
Earnings (Next)03-27 2026-03-27/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.49%
Ins Owner ChangeN/A
Market Cap21.99M
Revenue(TTM)25.50M
Net Income(TTM)-1.88M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.86 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 7.07 | ||
| P/tB | 9.08 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.2
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.87% | ||
| ROE | -60.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.95% | ||
| FCFM | N/A |
ROA(3y)-47.14%
ROA(5y)-65.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.65%
GM growth 5Y8.17%
F-Score5
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 72.12% | ||
| Cap/Sales | 2.18% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z | -4.67 |
F-Score5
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)42.25%
Cap/Depr(5y)69.89%
Cap/Sales(3y)2.21%
Cap/Sales(5y)24.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.41%
Revenue growth 3Y98.2%
Revenue growth 5Y172.32%
Sales Q2Q%1.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.69%
OCF growth 3YN/A
OCF growth 5YN/A
AVICANNA INC / AVCN.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of AVICANNA INC (AVCN.CA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA.
Can you provide the valuation status for AVICANNA INC?
ChartMill assigns a valuation rating of 0 / 10 to AVICANNA INC (AVCN.CA). This can be considered as Overvalued.
How profitable is AVICANNA INC (AVCN.CA) stock?
AVICANNA INC (AVCN.CA) has a profitability rating of 1 / 10.
How financially healthy is AVICANNA INC?
The financial health rating of AVICANNA INC (AVCN.CA) is 4 / 10.